Transactions
5
Insider / STERIS plc
FELDMANN CYNTHIA L
Director at STERIS plc
- Company
- STERIS plc
- Ticker
- STE
- First filing on record
- March 6, 2026
- Latest trade on record
- August 10, 2026
- SEC filings
- EDGAR ↗
FELDMANN CYNTHIA L, Director at STERIS plc, has disclosed 5 transactions in STE since March 6, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $1.2M at the reported prices. The latest was filed August 12, 2026, 2 days after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
1.4d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months FELDMANN CYNTHIA L made no purchases and 1 sale worth $735K, plus 4 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
FELDMANN CYNTHIA L has traded 1 stock on record; the largest by dollars is STE.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 2 | 2,018 | — |
| M | Option exercise or conversion | 2 | 6,196 | $472K |
| S | Open-market sale | 1 | 3,098 | $735K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 5 | 0 | 1 · $735K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| STE | Other A | August 10, 2026 | August 12, 2026 | 2d | 512 | — | — | derivative | Form 4 ↗ | |
| STE | Other A | August 10, 2026 | August 12, 2026 | 2d | 1,506 | — | — | derivative | Form 4 ↗ | |
| STE | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 3,098 | — | — | derivative | Form 4 ↗ | |
| STE | Sell S | March 5, 2026 | March 6, 2026 | 1d | 3,098 | $237 | $735K | Form 4 ↗ | ||
| STE | Option / conversion M | March 5, 2026 | March 6, 2026 | 1d | 3,098 | $152 | $472K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 12, 2026 | Form 4 | 0001628280-26-056261 | 2 | published | EDGAR ↗ |
| March 6, 2026 | Form 4 | 0001628280-26-015642 | 3 | published | EDGAR ↗ |
Other insiders at STERIS plc
- Sohi Mohsen Director 14 rows
- Madsen Julia Sr. VP and GM, Life Sciences 13 rows
- Tamaro Renato V.P. & Corporate Treasurer 12 rows
- Zangerle John Adam Sr. VP, Gen Counsel, and Sec. 11 rows
- Burton Karen L Sr. Vice Pres., CFO 10 rows
- Carestio Daniel A President and CEO 10 rows
- Fraser Mary Clare SVP & Chief HRO 7 rows
- Kohler Kenneth E SVP & GM, AST 6 rows
- Majors Cary L SVP and President, Healthcare 5 rows
- McGowan Lindsey VP, Chf. Comp. & Quality Offc. 5 rows
Everyone on file, with contracts and lobbying under the company's name: STERIS plc.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 5 | March 6, 2026 | August 12, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.